oxybutynin has been researched along with piroxicam in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Eid, SF; El-Houseny, SS; Nesseem, DI | 1 |
Cun, D; Fang, L; Guan, Y; Li, Y; Xi, H; Xiang, R; Zhang, Y | 1 |
Chantasart, D; Junyaprasert, VB; Teeranachaideekul, V; Tocanitchart, P; Wongrakpanich, A | 1 |
Ali, FR; Hashmat, D; Shoaib, MH; Siddiqui, F | 1 |
1 review(s) available for oxybutynin and piroxicam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for oxybutynin and piroxicam
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Lower Extremity; Male; Methacrylates; Piroxicam; Polyethylene Glycols; Polymers; Propylene Glycol; Rats; Rats, Wistar; Skin; Transdermal Patch | 2011 |
Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment?
Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Crotonates; Hydroxybutyrates; Male; Nitriles; Piroxicam; Rabbits; Rats; Toluidines; Transdermal Patch | 2013 |
Fabrication and evaluation of Eudragit
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Delivery Systems; Epidermis; Female; Humans; Middle Aged; Piroxicam; Polyethylene Glycols; Polymethacrylic Acids; Polyvinyl Alcohol; Skin Absorption; Transdermal Patch | 2018 |
Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Gels; Male; Oleic Acid; Piroxicam; Propylene Glycol; Rats; Rats, Wistar; Skin; Skin Absorption; Solvents; Transdermal Patch | 2020 |